Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification
Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100587
DOI: 10.1016/j.lddd.2026.100587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Chao Chen und 3 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Medical Association.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Zhejiang Medical Association
Zitieren
APA
Chen, C., Yang, L., Wang, Q., & Sun, T. (2026). Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification. Letters in Drug Design & Discovery, 23(9), 100587. https://doi.org/10.1016/j.lddd.2026.100587
Vancouver
Chen C, Yang L, Wang Q, Sun T. Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification. Letters in Drug Design & Discovery. 2026;23(9):100587. doi:10.1016/j.lddd.2026.100587
BibTeX
@article{Chen2026,
author = {Chen, Chao and Yang, Libin and Wang, Qianghui and Sun, Tao},
title = {Molecular mechanisms of the Longjin Tonglin Capsule in the treatment of LPS-induced prostatic inflammation: Network pharmacology and experimental verification},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {9},
pages = {100587},
doi = {10.1016/j.lddd.2026.100587}
}
EUVIMED